GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALNY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Alnylam Pharmaceuticals stock upgraded to Sell Candidate.
(Updated on Apr 18, 2024)

Sell candidate since Apr 12, 2024 Loss -2.25% PDF

The Alnylam Pharmaceuticals stock price fell by -0.110% on the last day (Thursday, 18th Apr 2024) from $145.32 to $145.16. It has now fallen 8 days in a row. During the last trading day the stock fluctuated 1.35% from a day low at $144.50 to a day high of $146.45. The price has fallen in 8 of the last 10 days and is down by -4.17% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -85 thousand shares and in total, 390 thousand shares were bought and sold for approximately $56.63 million.

The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $141.05, a level that may pose a second chance to hit a runner. According to fan-theory $158.57 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALNY Signals & Forecast

There are few to no technical positive signals at the moment. The Alnylam Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $148.27 and $149.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 22, 2024, and so far it has fallen -10.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Alnylam Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.95 (1.35%) between high and low. For the last week, the stock has had daily average volatility of 1.89%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALNY) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Alnylam Pharmaceuticals to open at $145.37, and during the day (based on 14 day Average True Range), to move between $141.30 and $149.02, which gives a possible trading interval of +/-$3.86 (+/-2.66%) up or down from last closing price. If Alnylam Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.32% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $147.00, some $1.84 (1.27%) from the current price of $145.16, our system finds the risk reward not very attractive.

Is Alnylam Pharmaceuticals stock A Buy?

Alnylam Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.166 Sell Candidate Upgraded

Predicted Opening Price for Alnylam Pharmaceuticals of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$145.37 ( 0.145%) $145.16

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALNY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 147.32 1.49 %
R2 146.58 0.97 %
R1 146.11 0.658 %
Current price: 145.16
Support S1 144.63 -0.368 %
S2 144.16 -0.686 %
S3 143.42 -1.20 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 154.74 6.60 %
R2 147.43 1.56 %
R1 147.00 1.27 %
Current price 145.16
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Alnylam Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Alnylam Pharmaceuticals is ALNY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Alnylam Pharmaceuticals Stock?
Alnylam Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Alnylam Pharmaceuticals Stock?
Alnylam Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Alnylam Pharmaceuticals Stock.

What's the current price of Alnylam Pharmaceuticals Stock?
As of the end of day on the 2024-04-18, the price of an Alnylam Pharmaceuticals (ALNY) share was $145.16.

What is the 52-week high and low for Alnylam Pharmaceuticals Stock?
The 52-week high for Alnylam Pharmaceuticals Stock is $218.88 and the 52-week low is $143.52.

What is the market capitalization of Alnylam Pharmaceuticals Stock?
As of the 2024-04-18, the market capitalization of Alnylam Pharmaceuticals is 18.302B.

When is the next earnings date for Alnylam Pharmaceuticals?
The upcoming earnings date for Alnylam Pharmaceuticals is May 02, 2024.
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT